Fundz

Heart Health Innovator Cleerly Closes Series C Funding Round With $192 Million

PRIVATEJul 25, 2022

Round Type

Series C

New YorkBiotechnologyHealth CareMedical

Description

Cleerly, the company creating a new standard of care for heart disease, announced that it has closed a Series C financing round of $192 million. This new funding brings the total raised by the fast-growing health care company to $248 million, which includes its Series B round in 2021.

Quick answer

Heart Health Innovator raised an undisclosed amount in a Series C round, dated July 25, 2022. Heart Health Innovator is based in New York, United States.

How much did Heart Health Innovator raise?
Heart Health Innovator raised an undisclosed amount in a Series C round on July 25, 2022.
What does Heart Health Innovator do?
In addition, the company will invest in additional large-scale outcomes research to establish it as the standard of care supporting physicians through personalized evaluation and treatment of heart disease.
Where is Heart Health Innovator based and how big is it?
Heart Health Innovator is based in New York, United States.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Heart Health Innovator that raised within 45 days of this round, from Fundz verified event records.

  • Tetra Bio-Pharma Inc. raised an undisclosed amount (Funding Round) on September 8, 2022.
  • Neochord raised $2.9M (Seed) on September 8, 2022.
  • Otolith Labs raised $20M (Series A) on September 7, 2022.
  • Monteris Medical raised $14M on September 2, 2022.
  • Abivax raised $49M (Funding Round) on September 2, 2022.
  • FathomX raised an undisclosed amount (Pre-Series A) on September 1, 2022.

Who to call at Heart Health Innovator, and when

A new round usually means Heart Health Innovator is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Heart Health Innovator raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Heart Health Innovator, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Heart Health Innovator. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Heart Health Innovator

Location

New York, United States

About

In addition, the company will invest in additional large-scale outcomes research to establish it as the standard of care supporting physicians through personalized evaluation and treatment of heart disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Heart Health Innovator raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Heart Health Innovator's next move

See what Strategic adds

Heart Health Innovator raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.